| Vol. 13.10 – 18 March, 2021 |
| |
|
|
| 37 cytokines/chemokines were identified at varying abundance, some of which involved in both chemotaxis and homeostasis of inflammatory cells and in positive remodeling of extracellular matrix, often damaged in tendinopathy and osteoarthritis. [Stem Cells Translational Medicine] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| The authors investigated the effect of human induced pluripotent stem cell-derived neural stem cells and umbilical cord-derived MSCs in a mouse model of acute spinal cord injury. [Stem Cell Research & Therapy] |
|
|
|
| Researchers elucidated whether human umbilical cord-derived MSCs can exert immunomodulatory effect and change the phenotype of activated microglia. [Cell Death Discovery] |
|
|
|
| Proliferation of Wharton’s jelly MSCs treated with Piper longum L. fruit extract was assessed by MTT assay and Cell Cycle Analysis. Effect of Piper longum L. preconditioning on osteogenic differentiation was performed. [Journal of Ethnopharmacology] |
|
|
|
| Scientists evaluated the effects of cultured media-MSCs on proliferation and apoptosis of CAL-27 and FaDu squamous cell carcinoma cell lines. [Gene] |
|
|
|
| The authors investigated the use of caprine Wharton’s Jelly MSCs on the survival and in vitro development of goat preantral follicles enclosed in ovarian fragments cultured for one or seven days. [Reproductive Sciences] |
|
|
|
| Researchers explored the possible therapeutic role of amniotic fluid-derived stem cells in improving busulfan-induced azoospermia in adult rats. [Tissue Engineering and Regenerative Medicine] |
| |
|
|
|
| MSCs currently constitute the most frequently used cell type in advanced therapies with different purposes, most of which are related with inflammatory processes. [Frontiers in Cell and Developmental Biology] |
|
|
|
|
| Celularity Inc. announced that the company has received Fast Track Designation from the FDA for its non-genetically modified cryopreserved human placental hematopoietic stem cell-derived natural killer cell therapy, CYNK-001, for the treatment of adults with recurrent glioblastoma multiforme. [Celularity, Inc.] |
|
|
|
| The South Korean government announced that it would spend 595 billion won ($525.6 million) by 2030 to support the country’s regenerative medicine sector. [The Korea Herald] |
|
|
|
|
| January 12 – 14, 2022 Shanghai, China |
|
|
|
|
|
| Gladstone Institute – San Francisco, California, United States |
|
|
|
| The University of Iowa – Iowa City, Iowa, United States |
|
|
|
| Cleveland Cord Blood Center – Cleveland, Ohio, United States |
|
|
|
| CyberCoders – San Diego, California, United States |
|
|
|
| Icahn School of Medicine at Mount Sinai – New York, New York, United States |
|
|
|
|